A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer von Socinski, M. A., Ivanova, A., Bakri, K., Wall, J., Baggstrom, M. Q., Hensing, T. A., Mears, A., Tynan, M., Beaumont, J., Peterman, A. H., Niell, H. B.

Volltext

A randomized phase II trial of erlotinib or erlotinib and bevacizumab in patients with advanced EGFR mutant non-small cell lung cancer (NSCLC) von Stinchcombe, T.E., Janne, P.A., Wang, X., Bertino, E.M., Weiss, J.M., Bazhenova, L., Gu, L., Lau, C.J., Paweletz, C.P., Jaslowski, A.J., Gerstner, G.J., Baggstrom, M.Q., Graziano, S.L., Bearden, J., Vokes, E.E.

Volltext

1444PA randomized phase II trial of erlotinib or erlotinib and bevacizumab in patients with advanced EGFR mutant non-small cell lung cancer (NSCLC) von Stinchcombe, T E, Janne, P A, Wang, X, Bertino, E M, Weiss, J M, Bazhenova, L, Gu, L, Lau, C J, Paweletz, C P, Jaslowski, A J, Gerstner, G J, Baggstrom, M Q, Graziano, S L, Bearden, J, Vokes, E E

Volltext

Final Results of a Phase 3 Trial of Celecoxib (C) in Addition to Standard Chemotherapy for Advanced Non–Small Cell Lung Cancer With COX- 2 Overexpression: CALGB 30801 (Alliance) von Edelman, M.J, Wang, X, Hodgson, L, Cheney, R.T, Baggstrom, M.Q, Sachdev, T, Gajra, A, Bertino, E.M, Reckamp, K.L, Molina, J, Schiller, J, Mitchell-Edwards, K, Friedman, P, Ritter, J, Milne, G, Stinchcombe, T.E, Hahn, O, Vokes, E.E

Volltext

A prospective study on the incidence of delayed nausea and vomiting following administration of carboplatin-containing regimens for treatment of cancer without prophylactic aprepit... von Pflederer, C., Goodgame, B. W., Morgensztern, D., Gao, F., Govindan, R., Baggstrom, M. Q.

Volltext

Patupilone combined with carboplatin in patients (pts) with advanced solid tumors: Preliminary safety and activity results von Baggstrom, M. Q., Ravaud, A., Fracasso, P. M.

Volltext

Phase II trial of R-(-)-gossypol acetic acid (NSC 726190, AT-101) in patients with recurrent extensive stage small cell lung cancer (ES-SCLC) von Baggstrom, M. Q., Govindan, R., Koczywas, M., Argiris, A., Millward, M., Johnson, E., Qi, Y., Erlichman, C.

Volltext

A survey on insomnia in patients with non-small cell lung cancer (NSCLC) von Subramanian, J., Baggstrom, M. Q., Gilstrap, E., De Shields, T., Boehmer, L., Williams, K., Devarakonda, S., Gao, F., Govindan, R.

Volltext

A prospective study on the incidence of delayed nausea and vomiting following administration of carboplatin containing regimens for treatment of cancer without prophylactic aprepit... von Waqar, M. A., Chitneni, P., Williams, K., Goodgame, B. W., Gao, F., Govindan, R., Baggstrom, M. Q.

Volltext

Trends in stage distribution for patients with non-small cell lung cancer: A National Cancer Database Survey von Morgensztern, D., Goodgame, B., Chitneni, P., Baggstrom, M. Q., Gao, F., Govindan, R.

Volltext

Patupilone combined with carboplatin in patients (pts) with advanced solid tumors: preliminary safety and activity results von Fracasso, P. M., Ravaud, A., Baggstrom, M. Q., LoRusso, P. M., Jones, D. V., Sguotti, C., Urban, P., Gao, B., Medioni, J.

Volltext

A phase I study of bexarotene and rosiglitazone in patients with refractory cancers von Read, W. L., Baggstrom, M. Q., Adkins, D., Suresh, R., Ghalie, R., Wildi, J., Govindan, R.

Volltext

Presentation of non-small cell lung cancer (NSCLC) in octogenarians von Velcheti, V., Viswanathan, A., Sainani, N., Grove, L., Suresh, R., Baggstrom, M. Q., Govindan, R.

Volltext

Lung cancer in never-smokers: A single institutional experience von Subramanian, J., Gao, F., Sainani, N., Viswanathan, A. K., Pillot, G. A., Baggstrom, M. Q., Sorscher, S., Govindan, R.

Volltext

Barriers for accrual to clinical trials in adult patients (pts) with thoracic malignancies von Baggstrom, M. Q., Gilstrap, E., Skelton, A., Viswanathan, A., Morgensztern, D., Nations, P. A., Foersterling, D., Govindan, R.

Volltext

A phase II trial of neo-adjuvant docetaxel (D) and estramustine (E) in patients with high risk/locally advanced prostate cancer von Baggstrom, M. Q., Rosenman, J., Pruthi, R., Whang, Y., Goyal, L., Grigson, G., Godley, P.

Volltext

A phase II trial of neo-adjuvant docetaxel (D) and estramustine (E) in patients with high risk/locally advanced prostate cancer von Baggstrom, M. Q., Rosenman, J., Pruthi, R., Whang, Y., Goyal, L., Grigson, G., Godley, P.

Volltext

American Society of Clinical Oncology Policy Statement: Oversight of Clinical Research von Adopted on November 7, 2002, by The American Society of Clinical Oncology

Volltext

Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base von Robinson, Cliff G, Patel, Aalok P, Bradley, Jeffrey D, DeWees, Todd, Waqar, Saiama N, Morgensztern, Daniel, Baggstrom, Maria Q, Govindan, Ramaswamy, Bell, Jennifer M, Guthrie, Tracey J, Colditz, Graham A, Crabtree, Traves D, Kreisel, Daniel, Krupnick, Alexander S, Patterson, G Alexander, Meyers, Bryan F, Puri, Varun

Volltext

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexp... von Edelman, Martin J, Wang, Xiaofei, Hodgson, Lydia, Cheney, Richard T, Baggstrom, Maria Q, Thomas, Sachdev P, Gajra, Ajeet, Bertino, Erin, Reckamp, Karen L, Molina, Julian, Schiller, Joan H, Mitchell-Richards, Kisha, Friedman, Paula N, Ritter, Jon, Milne, Ginger, Hahn, Olwen M, Stinchcombe, Thomas E, Vokes, Everett E

Volltext